Sinopharm China National Biotech Group Co., Ltd (CNBG) has announced partnerships with two foreign medical equipment firms to set up joint ventures (JVs) with majority stakes controlled by the state-owned company. This strategic move aims to enhance Sinopharm’s capabilities in the medical equipment sector.
Radiotherapy and Imaging Joint Ventures
Sinopharm’s subsidiary, China National Pharmaceutical Foreign Trade Corporation, is set to establish a joint venture focused on radiotherapy. Meanwhile, China National Medical Device Co., Ltd will collaborate with General Electric Medical Systems to create a joint venture specializing in CT and ultrasound products. These partnerships are expected to strengthen Sinopharm’s presence in the medical equipment market and improve access to advanced technologies.
Expanding Sinopharm’s Global Footprint
By forming these joint ventures, Sinopharm CNBG is poised to leverage the expertise and resources of its partners to develop innovative solutions in radiotherapy and imaging. This expansion aligns with the company’s broader strategy to enhance its global footprint and meet the growing demand for advanced medical equipment.-Fineline Info & Tech
